Efficacy and tolerability of a topical gel containing 3% hydrogen peroxide, 1.5% salicylic acid and 4% D-panthenol in the treatment of mild-moderate acne
- PMID: 26761768
Efficacy and tolerability of a topical gel containing 3% hydrogen peroxide, 1.5% salicylic acid and 4% D-panthenol in the treatment of mild-moderate acne
Abstract
Background: The aim of this paper was to evaluate efficacy and tolerability of a topical gel (ACNAID TM gel medical device) containing 3% hydrogen peroxide (HPO), 1.5% salicylic acid (SA) and 4% D-panthenol (D-p) in the treatment of mild-moderate acne, comparing it with a previous formulation (ACNAID TM gel Cosmetic) containing 4% HPO, 0.5% SA, 4% D-p.
Methods: Twenty patients of both sex with mild-moderate acne have been selected. The topical gel was applied twice a day for 60 days. Evaluations included: Global Acne Grading System (GAGS); lesions count; photographic assessment; a questionnaire to assess the tolerability. The results have been compared with those obtained in a previous study conducted with the formulation containing 4% HPO, 0.5% SA, 4% D-p.
Results: The GAGS score showed a reduction of 43% from T0 to T1 and of 61% from T0 to T2. Count of lesions: comedones reduction of 62% from T0 to T1 and of 95% from T0 to T2; papules reduction of 49% from T0 to T1 and of 68% from T0 to T2; pustules reduction of 75% from T0 to T1 and of 100% from T0 to T2. Digital images showed a significant reduction of acne lesions. At T2 the tolerability of the topical product was excellent according to 83% of patients and good according to 17% of patients.
Conclusions: The topical gel has demonstrated to be effective and safe for treatment of mild to moderate acne. No patients reported side effects. These results are superior to those obtained in the previous study.
Similar articles
-
Combination therapy with hydrogen peroxide (4%), salicylic acid (0.5%) and D-panthenol (4%): efficacy and skyn tolerability in common acne vulgaris during sun exposure period.Eur Rev Med Pharmacol Sci. 2016;20(2):232-6. Eur Rev Med Pharmacol Sci. 2016. PMID: 26875890
-
Evaluation of the efficacy, tolerability, and safety of an over-the-counter acne regimen containing benzoyl peroxide and salicylic acid in subjects with acne.J Drugs Dermatol. 2013 Mar;12(3):259-64. J Drugs Dermatol. 2013. PMID: 23545906 Clinical Trial.
-
A randomized controlled double-blinded split-face prospective clinical trial to assess the efficacy, safety, and tolerability of a novel 3-step routine compared to benzoyl peroxide for the treatment of mild to moderate acne vulgaris.Arch Dermatol Res. 2024 May 24;316(6):230. doi: 10.1007/s00403-024-02874-9. Arch Dermatol Res. 2024. PMID: 38787441 Clinical Trial.
-
Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.Am J Clin Dermatol. 2011 Dec 1;12(6):407-20. doi: 10.2165/11208170-000000000-00000. Am J Clin Dermatol. 2011. PMID: 21967116 Review.
-
Dapsone 7.5% Gel: A Review in Acne Vulgaris.Am J Clin Dermatol. 2017 Feb;18(1):139-145. doi: 10.1007/s40257-016-0242-0. Am J Clin Dermatol. 2017. PMID: 28005194 Review.
Cited by
-
Performance and Safety of the Medical Device Ialuxid Gel in the Treatment of Mild-Moderate Acne Vulgaris: An Open-Label, Noncomparative Multicentre Interventional Clinical Trial.J Cosmet Dermatol. 2025 Mar;24(3):e70084. doi: 10.1111/jocd.70084. J Cosmet Dermatol. 2025. PMID: 40029154 Free PMC article. Clinical Trial.
-
International expert consensus recommendations for the use of dermocosmetics in acne.J Eur Acad Dermatol Venereol. 2025 May;39(5):952-966. doi: 10.1111/jdv.20145. Epub 2024 Jun 15. J Eur Acad Dermatol Venereol. 2025. PMID: 38877766 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical